dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne 

Dyne Therapeutics, Inc. Common Stock

Sold all DYN

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Rahul

Sold 10% of DYN

New position in DYN

Jackson Rhodes

Theodore

Sold 33% of DYN

John

Bought 8% more DYN

Bought 22% more DYN